• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Viome Raises $25M To Launch Diagnostics Division

by Syed Hamza Sohail 09/10/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Viome, a pioneer in microbiome health science and personalized health solutions, today announced a $25 million internal Series D with participation from Khosla Ventures, Bold Capital WRG Ventures, Marc Benioff, and more.

–  This continued support from existing backers underscores their confidence in the company’s innovative approach and growth trajectory, reflected in its projected YoY increase.


Viome Appoints Kal Raman as COO to Accelerate Preventive Healthcare Innovations

Viome, a leading company in longevity and preventive healthcare, is advancing its mission to revolutionize early disease detection and preventative care through the appointment of Kal Raman as Chief Operating Officer (COO). Raman, known for his leadership roles at Amazon, Groupon, and Samsung, will drive the company’s expansion of diagnostic solutions aimed at combating chronic diseases, cancer, and aging.

With the increasing demand for advanced, personalized health solutions, Raman’s appointment comes at a pivotal time. The current healthcare model, where only 8% of Americans undergo routine preventive screenings and just 28% of patients are diagnosed at early stages, reflects the need for more proactive approaches to healthcare. Viome is well-positioned to address this gap by harnessing artificial intelligence and personalized solutions to enhance preventive care.

Raman’s extensive experience scaling business growth, enhancing automation, and driving strategic initiatives will support Viome’s efforts to introduce innovative diagnostic tests. The company has already set new standards in early cancer detection with its CancerDetect™ test, which boasts 90% sensitivity and 95% specificity. Building on this success, Viome plans to expand its diagnostics beyond oral and throat cancer to include gut health and other critical areas in the coming year. These efforts are further strengthened by the FDA Breakthrough Device Designation, which allows for accelerated review of their life-saving technologies.

Viome’s unique approach integrates groundbreaking RNA sequencing with artificial intelligence, analyzing epigenetic biomarkers to provide personalized nutritional guidance and microbiome health products. To date, the company has empowered over half a million users, offering AI-driven health insights to improve lifespan and well-being.

Kal Raman’s appointment underscores Viome’s commitment to its goal of making illness optional. By focusing on early detection and personalized health solutions, the company seeks to empower individuals to proactively manage their health, while also ensuring customer satisfaction and innovation remain top priorities.

“What attracted me to Viome was its mission to have a meaningful impact on the health of individuals. Viome is a true innovator and pioneer in the health space, being one of the first to recognize the critical importance of preventative measures. This is evident by the success of its microbiome tests, which have already helped thousands take control of their health through personalized insights and recommendations. I am excited to join a team that is at the forefront of transforming healthcare and am eager to help Viome achieve the same level of success in the diagnostics space”, said Kal Raman.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |